PDCD1 and cancer: Moreover, immune checkpoint inhibitors (ICIs) targeting the programmed cell death 1 (PD-1), the cytotoxic T-lymphocyte associated antigen 4 (CTLA-4), and other immunotherapy approaches have become standards of care for many cancers.